Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2016

01-12-2016 | Research Article

A quantitative comparison of ward-based clinical pharmacy activities in 7 acute UK hospitals

Authors: Raliat Onatade, Gavin Miller, Inderjit Sanghera

Published in: International Journal of Clinical Pharmacy | Issue 6/2016

Login to get access

Abstract

Background Several clinical pharmacy activities are common to UK hospitals. It is not clear whether these are provided at similar levels, and whether they take similar amounts of time to carry out. Objective To quantify and compare clinical pharmacist ward activities between different UK hospitals. Setting Seven acute hospitals in the Greater London area (UK). Methods A list of common ward activities was developed. On five consecutive days, pharmacists visiting hospital wards documented total time spent and how many of each activity they undertook. Results were analysed by hospital. The range and number of activities per 100 occupied bed days, and per 24 beds were compared. Main outcome measure Time spent on wards and numbers of each activity undertaken. Results Pharmacists logged a total of 2291 h carrying out 40,000 activities. 4250 changes to prescriptions were made or recommended. 5901 individual medication orders were annotated for clarity or safety. For every 24 beds visited, mean time spent was 230 min—seeing 6.2 new patients, carrying out 3.9 calculations and 1.3 patient consultations, checking and authorising 1.8 discharge prescriptions, and providing staff with information twice. Other activities varied significantly, not all could be explained by differences in hospital specialties or Information Technology systems. Conclusion This is the first detailed comparison of clinical pharmacy ward activities between different hospitals. There are some typical levels of activities carried out. Wide variations in other activities could not always be explained. Despite a large number of contacts, pharmacists reported very few consultation sessions with patients.
Literature
2.
go back to reference Royal Pharmaceutical Society. Medicines Optimisation: helping patients to make the most of medicines. London; 2013. Royal Pharmaceutical Society. Medicines Optimisation: helping patients to make the most of medicines. London; 2013.
3.
go back to reference Dornan T, Ashcroft D, Heathfield H, Lewis P, Miles J, Taylor D, et al. An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education. EQUIP study. Gen Med Counc Lond. 2009;44:1–215. Dornan T, Ashcroft D, Heathfield H, Lewis P, Miles J, Taylor D, et al. An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education. EQUIP study. Gen Med Counc Lond. 2009;44:1–215.
4.
go back to reference Stephens M. Hospital pharmacy. 2nd ed. London: Pharmaceutical Press; 2011. ISBN 978-0-85369-900-2. Stephens M. Hospital pharmacy. 2nd ed. London: Pharmaceutical Press; 2011. ISBN 978-0-85369-900-2.
5.
go back to reference American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28:816–7.CrossRef American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28:816–7.CrossRef
6.
go back to reference Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care. Arch Intern Med. 2006;166:955–64.CrossRefPubMed Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care. Arch Intern Med. 2006;166:955–64.CrossRefPubMed
7.
go back to reference Gallagher J, McCarthy S, Byrne S. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 2014;36:1101–14.CrossRefPubMed Gallagher J, McCarthy S, Byrne S. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 2014;36:1101–14.CrossRefPubMed
8.
go back to reference Fitzpatrick RW, Boardman HF. A survey of the provision of clinical pharmacy services in relation to existing published standards. Pharm World Sci. 2005;27:191–6.CrossRefPubMed Fitzpatrick RW, Boardman HF. A survey of the provision of clinical pharmacy services in relation to existing published standards. Pharm World Sci. 2005;27:191–6.CrossRefPubMed
9.
go back to reference Cotter S, Barber N, McKee M. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Hosp Pharm. 1994;51:2676–84.PubMed Cotter S, Barber N, McKee M. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals. Am J Hosp Pharm. 1994;51:2676–84.PubMed
10.
go back to reference Royal Pharmaceutical Society. Professional Standards for Hospital Pharmacy Services. London; 2014. Royal Pharmaceutical Society. Professional Standards for Hospital Pharmacy Services. London; 2014.
11.
go back to reference NICE. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. London; 2015. ISBN: 978-1-4731-1057-1. NICE. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. London; 2015. ISBN: 978-1-4731-1057-1.
13.
go back to reference Batty R, Beech E. Prescription monitoring interventions—is recording justified. Hosp Pharm. 1994;1:100. Batty R, Beech E. Prescription monitoring interventions—is recording justified. Hosp Pharm. 1994;1:100.
14.
go back to reference Alderman CP, Farmer C. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract. 2001;21:99–103.CrossRefPubMed Alderman CP, Farmer C. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract. 2001;21:99–103.CrossRefPubMed
15.
go back to reference Ball J. Guidance on safe nurse staffing levels in the UK. London; 2010. ISBN: 978-1-906633-60-8. Ball J. Guidance on safe nurse staffing levels in the UK. London; 2010. ISBN: 978-1-906633-60-8.
16.
go back to reference Darzi A. High quality care for all: NHS next stage review final report. Department of Health. London; 2008. Darzi A. High quality care for all: NHS next stage review final report. Department of Health. London; 2008.
17.
go back to reference Franklin BD, Rosa MB, Miller G, Jacklin A. The evaluation of a novel model of providing ward pharmacy services. Int J Clin Pharm. 2012;34:518–23.CrossRefPubMed Franklin BD, Rosa MB, Miller G, Jacklin A. The evaluation of a novel model of providing ward pharmacy services. Int J Clin Pharm. 2012;34:518–23.CrossRefPubMed
18.
go back to reference Donyai P, O’Grady K, Jacklin A, Barber N, Franklin BD. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol. 2008;65:230–7.CrossRefPubMed Donyai P, O’Grady K, Jacklin A, Barber N, Franklin BD. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol. 2008;65:230–7.CrossRefPubMed
19.
go back to reference Dodds LJ. Pharmacist contributions to ensuring safe and accurate transfer of written medicines-related discharge information: lessons from a collaborative audit and service evaluation involving 45 hospitals in England. Eur J Hosp Pharm Sci Pract. 2014;21:150–5.CrossRef Dodds LJ. Pharmacist contributions to ensuring safe and accurate transfer of written medicines-related discharge information: lessons from a collaborative audit and service evaluation involving 45 hospitals in England. Eur J Hosp Pharm Sci Pract. 2014;21:150–5.CrossRef
20.
go back to reference Onatade R, Wong A. Adaptable “scope of practice” template for hospital pharmacist prescribers. Pharm J. 2012;288:720. Onatade R, Wong A. Adaptable “scope of practice” template for hospital pharmacist prescribers. Pharm J. 2012;288:720.
21.
go back to reference Bourne RS, Baqir W, Onatade R. Pharmacist independent prescribing in secondary care: opportunities and challenges. Int J Clin Pharm. 2016;38:1–6.CrossRefPubMed Bourne RS, Baqir W, Onatade R. Pharmacist independent prescribing in secondary care: opportunities and challenges. Int J Clin Pharm. 2016;38:1–6.CrossRefPubMed
22.
go back to reference Baqir W, Crehan O, Murray R, Campbell D, Copeland R. Pharmacist prescribing within a UK NHS hospital trust: nature and extent of prescribing, and prevalence of errors. Eur J Hosp Pharm Sci Pract. 2014;22:79–82.CrossRef Baqir W, Crehan O, Murray R, Campbell D, Copeland R. Pharmacist prescribing within a UK NHS hospital trust: nature and extent of prescribing, and prevalence of errors. Eur J Hosp Pharm Sci Pract. 2014;22:79–82.CrossRef
23.
go back to reference Carter, L. Operational productivity and performance in English NHS acute hospitals: unwarranted variations. London; 2016. Carter, L. Operational productivity and performance in English NHS acute hospitals: unwarranted variations. London; 2016.
Metadata
Title
A quantitative comparison of ward-based clinical pharmacy activities in 7 acute UK hospitals
Authors
Raliat Onatade
Gavin Miller
Inderjit Sanghera
Publication date
01-12-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 6/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0386-2

Other articles of this Issue 6/2016

International Journal of Clinical Pharmacy 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.